These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2576531)

  • 1. Thresholds for the physiologic effects of adrenergic agents: a methodologic appraisal.
    Padbury JF; Habib DM; Martinez AM
    Dev Pharmacol Ther; 1989; 14(2):115-24. PubMed ID: 2576531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of aging on anesthetic pharmacology.
    Muravchick S
    Acta Anaesthesiol Belg; 1998; 49(2):79-84. PubMed ID: 9675376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenergic drugs alter both the fluid kinetics and the hemodynamic responses to volume expansion in sheep.
    Ewaldsson CA; Vane LA; Kramer GC; Hahn RG
    J Surg Res; 2006 Mar; 131(1):7-14. PubMed ID: 16325856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dobutamine pharmacokinetics and pharmacodynamics in normal children and adolescents.
    Berg RA; Padbury JF; Donnerstein RL; Klewer SE; Hutter JJ
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1232-8. PubMed ID: 8510005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of agonist efficacy and receptor phosphorylation on antagonist affinity measurements: differences between second messenger and reporter gene responses.
    Baker JG; Hall IP; Hill SJ
    Mol Pharmacol; 2003 Sep; 64(3):679-88. PubMed ID: 12920204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effects of alpha2-adrenergic receptor agonists.
    Weber B; Steinfath M; Scholz J; Bein B
    Drug News Perspect; 2007 Apr; 20(3):149-54. PubMed ID: 17520091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of epinephrine on lung liquid production by in vitro lungs from fetal guinea pigs.
    Woods BA; Doe S; Perks AM
    Can J Physiol Pharmacol; 1997 Jul; 75(7):772-80. PubMed ID: 9315343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory pain in the rabbit: a new, efficient method for measuring mechanical hyperalgesia in the hind paw.
    Dong H; Sun H; Magal E; Ding X; Kumar GN; Chen JJ; Johnson EJ; Manning BH
    J Neurosci Methods; 2008 Feb; 168(1):76-87. PubMed ID: 18022246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related alterations in the cardiovascular response to adrenergic mediated stress.
    Lakatta EG
    Fed Proc; 1980 Dec; 39(14):3173-7. PubMed ID: 6108242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of BKCa channel modulators with adrenergic agonists in the rat aorta is influenced by receptor reserve.
    El-Hajj H; Chandrasekhar B; Kadavil EA; Oriowo MA
    Vascul Pharmacol; 2004; 41(4-5):119-24. PubMed ID: 15607494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
    Brent RL
    Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?
    Jonker DM; Voskuyl RA; Danhof M
    Epilepsia; 2007 Mar; 48(3):412-34. PubMed ID: 17346245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concentration-response relationship of levodopa in patients at different stages of Parkinson's disease.
    Harder S; Baas H
    Clin Pharmacol Ther; 1998 Aug; 64(2):183-91. PubMed ID: 9728899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Teaching principles of cardiovascular function in a medical student laboratory.
    Gupta S; Westfall TC; Lechner AJ; Knuepfer MM
    Adv Physiol Educ; 2005 Jun; 29(2):118-27. PubMed ID: 15905157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do dose response thresholds exist for genotoxic alkylating agents?
    Jenkins GJ; Doak SH; Johnson GE; Quick E; Waters EM; Parry JM
    Mutagenesis; 2005 Nov; 20(6):389-98. PubMed ID: 16135536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo.
    Ney P; Pandita RK; Newgreen DT; Breidenbach A; Stöhr T; Andersson KE
    BJU Int; 2008 Apr; 101(8):1036-42. PubMed ID: 18279452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tryptamine-based human beta3-adrenergic receptor agonists. Part 3: improved oral bioavailability via modification of the sulfonamide moiety.
    Sawa M; Mizuno K; Harada H; Tateishi H; Arai Y; Suzuki S; Oue M; Tsujiuchi H; Furutani Y; Kato S
    Bioorg Med Chem Lett; 2005 Feb; 15(4):1061-4. PubMed ID: 15686912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extrapolating from animal studies to the efficacy in humans of a pretreatment combination against organophosphate poisoning.
    Levy A; Cohen G; Gilat E; Kapon J; Dachir S; Abraham S; Herskovitz M; Teitelbaum Z; Raveh L
    Arch Toxicol; 2007 May; 81(5):353-9. PubMed ID: 17009047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.